Literature DB >> 17941684

Site-specific pegylation of G-CSF by reversible denaturation.

Francesco M Veronese1, Anna Mero, Francesca Caboi, Mauro Sergi, Christian Marongiu, Gianfranco Pasut.   

Abstract

A new strategy has been developed for extending the possibility of poly(ethylene glycol) (PEG) modification to accessible thiol groups of biologically active proteins. In particular, thiol-reactive PEGs have been coupled to the cysteine 17 of granulocyte colony stimulating factor (G-CSF), which is known to be partially buried in a hydrophobic protein pocket. The PEG linking was accomplished by partial protein denaturation with 3 M guanidine.HCl in the absence of any reducing agent in order to preserve the native protein's disulfide bridges. PEG coupling occurred also, but at a lower degree, by using a 3 M solution of urea as the denaturing agent. Following the PEGylation, which was carried out in the unfolded state, the conjugated protein was refolded using dialysis or gel filtration chromatography to eliminate the denaturant. Different thiol-reactive PEGs and polymer molecular weights (5, 10, or 20 kDa) were investigated for G-CSF conjugation under denaturation. The secondary structure of the protein in the G-CSF-PEG conjugates, evaluated using circular dichroism and biological activity assay in cell culture, was maintained with respect to the native protein. Unexpectedly, conjugation enhanced the G-CSF tendency to aggregate, a problem that was overcome by a proper formulation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17941684     DOI: 10.1021/bc070123+

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  13 in total

1.  Conformational and aggregation properties of a PEGylated alanine-rich polypeptide.

Authors:  Ayben Top; Christopher J Roberts; Kristi L Kiick
Journal:  Biomacromolecules       Date:  2011-05-09       Impact factor: 6.988

2.  Impact of the PEG length and PEGylation site on the structural, thermodynamic, thermal, and proteolytic stability of mono-PEGylated alpha-1 antitrypsin.

Authors:  Xiao Liu; Kobenan G W Kouassi; Rita Vanbever; Mireille Dumoulin
Journal:  Protein Sci       Date:  2022-09       Impact factor: 6.993

Review 3.  Delivery of therapeutic proteins.

Authors:  Dipak S Pisal; Matthew P Kosloski; Sathy V Balu-Iyer
Journal:  J Pharm Sci       Date:  2010-06       Impact factor: 3.534

4.  PEGylation-aided refolding of globular adiponectin.

Authors:  Mingming Gao; Yue Tong; Xiangdong Gao; Wenbing Yao
Journal:  World J Microbiol Biotechnol       Date:  2013-03-20       Impact factor: 3.312

5.  A better anti-diabetic recombinant human fibroblast growth factor 21 (rhFGF21) modified with polyethylene glycol.

Authors:  Zhifeng Huang; Huiyan Wang; Meifei Lu; Chuanchuan Sun; Xiaoping Wu; Yi Tan; Chaohui Ye; Guanghui Zhu; Xiaojie Wang; Lu Cai; Xiaokun Li
Journal:  PLoS One       Date:  2011-06-06       Impact factor: 3.240

6.  Establishment of the first international standard for PEGylated granulocyte colony stimulating factor (PEG-G-CSF): report of an international collaborative study.

Authors:  Meenu Wadhwa; Chris Bird; Thomas Dougall; Peter Rigsby; Adrian Bristow; Robin Thorpe
Journal:  J Immunol Methods       Date:  2014-10-25       Impact factor: 2.303

7.  Biophysical characterization of Met-G-CSF: effects of different site-specific mono-pegylations on protein stability and aggregation.

Authors:  Antonino Natalello; Diletta Ami; Maddalena Collini; Laura D'Alfonso; Giuseppe Chirico; Giancarlo Tonon; Silvia Scaramuzza; Rodolfo Schrepfer; Silvia Maria Doglia
Journal:  PLoS One       Date:  2012-08-08       Impact factor: 3.240

8.  G-CSF/anti-G-CSF antibody complexes drive the potent recovery and expansion of CD11b+Gr-1+ myeloid cells without compromising CD8+ T cell immune responses.

Authors:  Mark P Rubinstein; Mohamed L Salem; Andrew L Doedens; Caitlin J Moore; Cody Chiuzan; Guillermo L Rivell; David J Cole; Ananda W Goldrath
Journal:  J Hematol Oncol       Date:  2013-10-01       Impact factor: 17.388

9.  PEGylation of Truncated Streptokinase Leads to Formulation of a Useful Drug with Ameliorated Attributes.

Authors:  Pooja Sawhney; Keya Katare; Girish Sahni
Journal:  PLoS One       Date:  2016-05-18       Impact factor: 3.240

10.  Semisynthetic prion protein (PrP) variants carrying glycan mimics at position 181 and 197 do not form fibrils.

Authors:  Can Araman; Robert E Thompson; Siyao Wang; Stefanie Hackl; Richard J Payne; Christian F W Becker
Journal:  Chem Sci       Date:  2017-07-24       Impact factor: 9.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.